Middle East And Africa Pharmacy Automation Market
Market Size in USD Billion
CAGR : %
Forecast Period |
2024 –2030 |
Market Size (Base Year) |
|
Market Size (Forecast Year) |
|
CAGR |
|
Major Markets Players |
Middle East and Africa Pharmacy Automation Market, By Product (Systems, Software, and Services), Pharmacy Type (Independent, Chain, and Federal), Pharmacy Size (Large Size Pharmacy, Medium Size Pharmacy, and Small Size Pharmacy), Application (Drug Dispensing and Packaging, Drug Storage, and Inventory Management), End User (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies, Online Pharmacies, Central Fill/Mail Order Pharmacies, Pharmacy Benefit Management Organizations, and Others), Distribution Channel (Direct Tender and Third Party Distributor) - Industry Trends and Forecast to 2030.
Middle East and Africa Pharmacy Automation Market Analysis and Insights
The rising incidence of accidents and deaths due to medical drug errors puts tremendous pressure on the general healthcare sector. Both healthcare professionals and pharmacists are searching for more effective and accurate solutions to avoid such frequent medical malfunctions. In addition, with the increasing number of patients, visitors, and their respective safety needs, the drug delivery system becomes more complicated each passing day. In order to tackle this serious issue, advanced technologies such as pharmacy automation systems are now emerging as the most powerful tools. The goal of these instruments is to reduce medical prescription errors and maximize patient safety. Therefore, implementing such pharmacy automation systems helps healthcare service providers and pharmacists minimize their losses and improve quality and productivity.
In addition, the implementation of technological innovations and the advancement of automated systems with improved pharmacy automation systems lead to higher success rates and new applications of devices with higher demand for innovative products for prescription medicines for compounding, dispensing, storing, and labeling are driving the market growth over the forecast period. However, it is anticipated that factors such as reluctance in implementing pharmacy automation systems due to their high cost would restrict their adoption, which is expected to restrain the market growth.
The Middle East and Africa pharmacy automation market is supportive and aims to reduce medication dispensing errors and improve patient safety. Data Bridge Market Research analyzes that the Middle East and Africa pharmacy automation market will grow at a CAGR of 7.7% during the forecast period of 2023 to 2030.
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Year |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in Million and Pricing in USD |
Segments Covered |
Product (Systems, Software, and Services), Pharmacy Type (Independent, Chain, and Federal), Pharmacy Size (Large Size Pharmacy, Medium Size Pharmacy, and Small Size Pharmacy), Application (Drug Dispensing and Packaging, Drug Storage, and Inventory Management), End User (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies, Online Pharmacies, Central Fill/Mail Order Pharmacies, Pharmacy Benefit Management Organizations, and Others), Distribution Channel (Direct Tender and Third Party Distributor) |
Countries Covered |
Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and rest of Middle East and Africa |
Market Players Covered |
ARxIUM, OMNICELL INC., Cerner Corporation, Capsa Healthcare, ScriptPro LLC, RxSafe, LLC., MedAvail Technologies, Inc., Asteres Inc., InterLink AI, Inc., BD, Baxter, Fullscript, McKesson Corporation, Innovation Associates, AmerisourceBergen Corporation, UNIVERSAL LOGISTICS HOLDINGS, INC, Takazono Corporation, TOSHO Inc., Willach Group, BIQHS, Synergy Medical, Yuyama, APD Algoritmos Procesos y Diseños S.A, JVM Europe BV, Genesis Automation LTD, myPak Solutions Pty Ltd., Demodeks Pharmacy Shelving, Deenova S.r.l., KUKA AG, and KLS Pharma Robotics GmbH among others |
Market Definition
Pharmacy automation plays a significant role in modern healthcare as it allows medicine to be conveniently delivered and distributed in the hospital pharmacy or retail pharmacy. Automation of the pharmacy helps to reduce the error in the medication. It prevents errors such as missing medication information, missing patient information, dispensing formulations, prescription errors, tracking therapy, and others that can occur during the manual process. One of the most common types of errors is incorrect labeling information and instructions. To improve healthcare facilities and services and to ensure patient safety, it is vital to reduce prescription error, which is why the pharmacy automation system is used in quite important ways to eliminate storage, inventory, usage, and retrieval error. The use of pharmacy automation is highly acceptable and beneficial in increasing the efficiency and accuracy of pharmacies. Furthermore, the need for preventing medication errors and the rising geriatric population across the globe are likely to boost the market growth in the forecast period.
Middle East and Africa Pharmacy Automation Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
DRIVERS
- Growing Need to Minimize Medication Errors
Medical errors are the leading cause of death in countries, further leading to increased hospitalization worldwide. Medication errors are of various types that include errors in the chain of pharmacological and pharmaceutical patient care: prescription errors, dispensing errors, administration errors, transcription errors, prescribing faults, and ‘across settings’ errors.
A medication mistake can occur due to a number of variables, such as inadequate order coordination between the doctor and pharmacist, improper storage practices in pharmacies, and misunderstandings arising from the use of identical labels.
Dispensing errors include any anomalies or deviations from the prescribing order, such as dispensing the wrong dose, drug, dosage type, incorrect amount, or insufficient, incorrect, or inadequate labeling. The misleading or insufficient instruction for use, improper planning, packaging, or storage of medication before dispensing is also considered a medication error.
In a pharmacy that fills 250 prescriptions per day, errors occur at a rate of 4 per day, amounting to an estimated 51.5 million errors out of 3 billion prescriptions filled annually across the nation.
- Rising Demand for Pharmaceuticals
The escalating demand for pharmaceuticals is observed across the globe due to the surging incidence of chronic diseases such as cancers, diabetes, obesity, and asthma among others. The people suffering from these diseases are dependent on one or the other medication prescribed to them by their physicians.
Also, the aging population is increasing Middle East and Africa due to the availability of better healthcare facilities. Increased research and development leading to the launch of effective and novel medications oriented to specific diseases further aids in the surging demand for pharmaceuticals.
Moreover, the emergence of COVID-19 also has increased the demand for various medications worldwide which include vitamin-C tablets and hydroxychloroquine, among others leading to a significant rise in the demand for pharmaceuticals.
OPPORTUNITY
- Need for Increasing the Efficiency of Work within the Pharmacies
Every pharmacy is trying to do the same things which include correctly and efficiently filling prescriptions, providing high-quality patient care, and maintaining a sustainable business model in which workers have good job satisfaction and consumers are satisfied.
In order to improve the effectiveness of their pharmacy activities in support of overall hospital strategies and priorities to provide high-quality patient-centered care, many hospital and pharmacy leaders have started adopting pharmacy automation systems.
The adoption of enhanced workflow and pharmacy automation software and system has potentially increased the efficiency of the pharmacies. Thereby, the need for increasing the efficiency of work within the pharmacies acts as an opportunity for market growth.
RESTRAINT
- High Capital Investment
Pharmacy automation systems are more costly as compared to manual systems. The price of an average pharmacy automation system starts at USD 59,198.45 but for more exotic versions, it can be as high as USD 591,984.50.
Since the capital investment needed for the pharmacy automation system implementation is significantly high, it makes it difficult to adopt such systems in hospitals and pharmacies in developing nations along with small pharmacies across the globe. Thus, the high capital investment leads to the decreased adoption rate of pharmacy automation systems. Hence, it acts as a restraint for market growth.
CHALLENGE
- Stringent Regulatory Procedures
Hospitals and pharmacies are required to play a crucial role in the drug supply chain of the nation: the distribution of medicines to the public. Among the several regulations — state and federal — that regulate medicine dispensing practices, there are 3 important laws relating to the protection and security of both the general public and practitioners in the industry.
These laws apply to Drug supply chain protection, controlled substance regulation and safety, and pharmaceutical hazardous waste management — and are implemented by the FDA, DEA, and EPA.
Manufacturers of automated pharmaceutical systems, therefore, have to comply with various regulations; maintaining such compliance is a tedious job and can delay product launches. Thus, the stringency of regulatory procedures acts as a challenge to market growth.
Recent Developments
- In January 2023, AmerisourceBergen Corporation announced the completion of its acquisition of PharmaLex Holding GmbH. The acquisition of PharmaLex enhances AmerisourceBergen Corporation’s growth strategy by advancing its leadership in specialty services and Middle East and Africa platform of pharma manufacturer services capabilities.
- In February 2022, Baxter announced that it has received authorization from the Common Vulnerability and Exposures (CVE) program to be a CVE Numbering Authority.
Middle East and Africa Pharmacy Automation Market
The Middle East and Africa pharmacy automation market is segmented into six notable segments based on product, pharmacy type, pharmacy size, application, end user, and distribution channel.
PRODUCT
- SYSTEMS
- SOFTWARE
- SERVICES
On the basis of product, the market is segmented into systems, software, and services.
PHARMACY TYPE
- INDEPENDENT
- CHAIN
- FEDERAL
On the basis of pharmacy type, the market is segmented into independent, chain, and federal.
PHARMACY SIZE
- LARGE SIZE PHARMACY
- MEDIUM SIZE PHARMACY
- SMALL SIZE PHARMACY
On the basis of pharmacy size, the market is segmented into large size pharmacy, medium size pharmacy, and small size pharmacy.
APPLICATION
- DRUG DISPENSING AND PACKAGING
- DRUG STORAGE
- INVENTORY MANAGEMENT
On the basis of application, the market is segmented into drug dispensing and packaging, drug storage, and inventory management.
END USER
- INPATIENT PHARMACIES
- OUTPATIENT PHARMACIES
- RETAIL PHARMACIES
- ONLINE PHARMACIES
- CENTRAL FILL/MAIL ORDER PHARMACIES
- PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS
- OTHERS
On the basis of end user, the market is segmented into inpatient pharmacies, outpatient pharmacies, retail pharmacies, online pharmacies, central fill/mail order pharmacies, pharmacy benefit management organizations, and others.
DISTRIBUTION CHANNEL
- DIRECT TENDER
- THIRD PARTY DISTRIBUTOR
On the basis of distribution channel, the market is segmented into direct tender and third party distributor.
Middle East and Africa Pharmacy Automation Market Regional Analysis/Insights
The Middle East and Africa pharmacy automation market is segmented into six notable segments based on product, pharmacy type, pharmacy size, application, end user, and distribution channel.
The countries covered in this market report are Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and the rest of Middle East and Africa.
In 2023, Saudi Arabia is expected to dominate the market due to rising awareness about the advantages of pharmacy automation systems over manual methods.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and the challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Middle East and Africa Pharmacy Automation Market Share Analysis
The Middle East and Africa pharmacy automation market competitive landscape provides details of the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the market.
Some of the major market players operating in the Middle East and Africa pharmacy automation market are Cerner Corporation, Capsa Healthcare, ScriptPro LLC, RxSafe, LLC., MedAvail Technologies, Inc., Asteres Inc., InterLink AI, Inc., BD, Baxter, Fullscript, McKesson Corporation, Innovation Associates, AmerisourceBergen Corporation, UNIVERSAL LOGISTICS HOLDINGS, INC
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: REGULATIONS
4.1 EXISTING STATE LAWS AND REGULATIONS FOR THE USE OF AUTOMATED DISPENSING SYSTEMS (ADS) IN THE U.S.
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING NEED TO MINIMIZE MEDICATION ERRORS
5.1.2 RISING DEMAND FOR PHARMACEUTICALS
5.1.3 RISING LABOR COST
5.1.4 ADVANTAGES OF PHARMACY AUTOMATION SYSTEMS OVER MANUAL METHODS
5.1.5 TECHNOLOGICAL ADVANCEMENTS AND PRECISE ROBOTIC TOOLS
5.2 RESTRAINTS
5.2.1 RELUCTANCE AMONG THE HEALTHCARE ORGANIZATIONS TO ADOPT PHARMACY AUTOMATION SYSTEMS
5.2.2 HIGH CAPITAL INVESTMENT
5.2.3 INTEROPERABILITY PROBLEMS IN PHARMACY AUTOMATION
5.3 OPPORTUNITIES
5.3.1 NEED FOR INCREASING THE EFFICIENCY OF WORK WITHIN THE PHARMACIES
5.3.2 RISING HEALTHCARE EXPENDITURE IN EMERGING NATIONS
5.3.3 STRATEGIC INITIATIVES OF KEY MARKET PLAYERS
5.4 CHALLENGES
5.4.1 STRINGENCY OF REGULATORY PROCEDURES
5.4.2 SKILLED WORK-FORCE CHALLENGES
5.4.3 LIMITATIONS OF PHARMACY AUTOMATION SYSTEMS
6 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY PRODUCT
6.1 OVERVIEW
6.2 SYSTEMS
6.3 SOFTWARE
6.4 SERVICES
7 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY PHARMACY TYPE
7.1 OVERVIEW
7.2 INDEPENDENT
7.3 CHAIN
7.4 FEDERAL
8 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY PHARMACY SIZE
8.1 OVERVIEW
8.2 LARGE SIZE PHARMACY
8.3 MEDIUM SIZE PHARMACY
8.4 SMALL SIZE PHARMACY
9 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISPENSING AND PACKAGING
9.3 DRUG STORAGE
9.4 INVENTORY MANAGEMENT
10 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY END USER
10.1 OVERVIEW
10.2 INPATIENT PHARMACIES
10.3 OUTPATIENT PHARMACIES
10.4 RETAIL PHARMACIES
10.5 ONLINE PHARMACIES
10.6 CENTRAL FILL/MAIL ORDER PHARMACIES
10.7 PHARMACY BENEFIT MANAGEMENT ORGANIZATIONS
10.8 OTHERS
11 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTOR
12 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, BY REGION
12.1 MIDDLE EAST & AFRICA
12.1.1 SAUDI ARABIA
12.1.2 SOUTH AFRICA
12.1.3 U.A.E.
12.1.4 ISRAEL
12.1.5 EGYPT
12.1.6 REST OF MIDDLE EAST & AFRICA
13 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 OMNICELL, INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 MCKESSON CORPORATION
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.3 AMERISOURCEBERGEN CORPORATION
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 BAXTER
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENTS
15.5 TOSHO CO., INC.
15.5.1 COMPANY SNAPSHOT
15.5.2 COMPANY SHARE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENTS
15.6 APD ALGORITMOS PROCESOS Y DISEÑOS S.A.
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 ASTERES INC.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ARXIUM
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 BD
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 COMPANY SHARE ANALYSIS
15.9.4 PRODUCT PORTFOLIO
15.9.5 RECENT DEVELOPMENTS
15.1 BIQHS
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 CAPSA HEALTHCARE
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 CERNER CORPORATION
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENTS
15.13 DEENOVA S.R.L.
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENTS
15.14 DEMODEKS PHARMACY SHELVING
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENTS
15.15 FULLSCRIPT
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENTS
15.16 GENESIS AUTOMATION LTD
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENTS
15.17 IA
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 INTERLINK AI, INC
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENTS
15.19 JVM EUROPE BV
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENTS
15.2 KLS PHARMA ROBOTICS GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 KUKA AG
15.21.1 COMPANY SNAPSHOT
15.21.2 REVENUE ANALYSIS
15.21.3 COMPANY SHARE ANALYSIS
15.21.4 PRODUCT PORTFOLIO
15.21.5 RECENT DEVELOPMENTS
15.22 MEDAVAIL TECHNOLOGIES, INC.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENTS
15.23 MYPAK SOLUTIONS PTY LTD.
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 RXSAFE, LLC.
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 SCRIPTPRO LLC
15.25.1 COMPANY SNAPSHOT
15.25.2 COMPANY SHARE ANALYSIS
15.25.3 PRODUCT PORTFOLIO
15.25.4 RECENT DEVELOPMENTS
15.26 SYNERGY MEDICAL
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
15.27 TAKAZONO CORPORATION
15.27.1 COMPANY SNAPSHOT
15.27.2 PRODUCT PORTFOLIO
15.27.3 RECENT DEVELOPMENTS
15.28 UNIVERSAL LOGISTICS HOLDINGS, INC.
15.28.1 COMPANY SNAPSHOT
15.28.2 REVENUE ANALYSIS
15.28.3 PRODUCT PORTFOLIO
15.28.4 RECENT DEVELOPMENTS
15.29 WILLACH GROUP
15.29.1 COMPANY SNAPSHOT
15.29.2 PRODUCT PORTFOLIO
15.29.3 RECENT DEVELOPMENTS
15.3 YUYAMA
15.30.1 COMPANY SNAPSHOT
15.30.2 PRODUCT PORTFOLIO
15.30.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Figure
FIGURE 1 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: SEGMENTATION
FIGURE 11 GROWING NEED TO MINIMIZE MEDICATION ERRORS IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 SYSTEMS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET
FIGURE 14 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PRODUCT, 2022
FIGURE 15 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PRODUCT, 2023-2030 (USD
FIGURE 16 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2022
FIGURE 19 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY TYPE, LIFELINE CURVE
FIGURE 22 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2022
FIGURE 23 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PHARMACY SIZE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY APPLICATION, 2022
FIGURE 27 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY END USER, 2022
FIGURE 31 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: SNAPSHOT (2022)
FIGURE 39 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY COUNTRY (2022)
FIGURE 40 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: BY PRODUCT (2023-2030)
FIGURE 43 MIDDLE EAST & AFRICA PHARMACY AUTOMATION MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.